Testing a Serum for Aging Skin in Adults on GLP-1 Meds
Part of Genetic & congenital, Skin clinical trials.
This study tests a topical serum designed to improve visible signs of facial aging, such as fine lines and skin texture. It is looking specifically at men and women aged 25–50 who are already taking a GLP-1 medication like Ozempic, and want to see if adding this serum helps their skin look younger.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 50 years old.
- You are currently taking Ozempic, Rybelsus, or Wegovy for weight or diabetes management, and have been on it for at least 6 months.
- You have mild to moderate signs of facial aging like fine lines, loose skin, or dull texture.
- You are in good general health and not pregnant or breastfeeding.
- You have not had other cosmetic facial treatments (like fillers, lasers, or microneedling) in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new facial serum (AGE Serum) designed to improve signs of aging like fine lines and loose skin in post-menopausal women who are taking GLP-1 medications (like Ozempic or Wegovy). Researchers want to see if it's safe and if it actually works to improve how the skin looks.
This study tests whether injections of poly-L-lactic acid (a collagen-boosting filler) can improve loose skin on the belly in women taking or not taking GLP-1 medications (like Ozempic or Wegovy). It aims to help people who have mild to moderate loose skin and are at a stable weight.
This trial tests a new injectable collagen product called MEC REGENERATE® to see if it is safe and works well for improving the appearance of facial skin. It may be an option if you are looking for a non-surgical aesthetic treatment.
This trial tests whether a hyaluronic acid filler (a gel injected into the skin) can improve skin quality in women who are taking or not taking GLP-1 medications (like Ozempic or Wegovy). It aims to see if the filler helps with skin radiance, elasticity, tone, firmness, fine lines, wrinkles, and smoothness.
This trial tests a serum and cream to see if they reduce signs of aging like wrinkles and dryness. It may be a good fit if you have mild to moderate skin aging and are willing to follow a daily skincare routine.
This study tests an oral supplement to see if it improves signs of facial skin aging in healthy adults. Participants take the supplement daily for 8 weeks and undergo two small skin biopsies on the upper arms to measure changes.
Hear when a new Laxity; Skin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.